UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification ...

Sanuwave Health (SNWV) Q4 2022 Earnings Call April 03, 2023 09:00 AM ET Speaker0 Please note this conference is being recorded. I will now turn the conference over to Kevin Richardson, CEO. Thank you. You may begin. Speaker1 Thank you, Sherry. Welcome to SANUWAVE's fourth quarter and full year twenty twenty two earnings call. The 10 ks was filed with the SEC Friday night. Our earnings release was issued this morning and our updated investor presentation was made available on our website in the Investors sec ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to. Commission File Number: 000-52985 SANUWAVE Health, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 20-1176000 (State or Other Jurisdiction of Incorporation) ...